Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
60.27
USD
-1.00 (-1.63%)
Streaming Delayed Price
Updated: 11:51 AM EST, Mar 3, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,813,726
Open
61.05
Bid (Size)
60.26 (10)
Ask (Size)
60.27 (7)
Prev. Close
61.27
Today's Range
59.97 - 61.35
52wk Range
45.76 - 67.16
Shares Outstanding
1,634,538,458
Dividend Yield
2.65%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference
March 02, 2021
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference
From
Business Wire News Releases
Bristol Myers Squibb Announces Dividend
March 01, 2021
Bristol Myers Squibb Announces Dividend
From
Business Wire News Releases
Performance
YTD
-1.81%
-1.81%
1 Month
-3.12%
-3.12%
3 Month
-3.43%
-3.43%
6 Month
-1.15%
-1.15%
1 Year
-0.12%
-0.12%
More News
Read More
SPLV, KCNY: Big ETF Outflows
Today 10:49 EST
Tags
ETFs
From
ETF Channel
Are These Top Health Care Stocks Worth Watching Ahead Of March?
February 25, 2021
Tags
Market News
From
StockMarket.com
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
February 26, 2021
From
Business Wire News Releases
7 Value Stocks Ready for the Next 10 Years
March 01, 2021
Tags
CRON
MO
BUD
From
InvestorPlace
Warren Buffett Says Berkshire's Apple Investment Shows The 'Power Of Repurchases'
March 01, 2021
Tags
Trading Ideas
Stock Repurchase
ABBV
From
Benzinga
The New England Journal of Medicine Publishes Results from Pivotal Phase 2 KarMMa Study of Idecabtagene Vicleucel (Ide-cel, bb2121), an Investigational BCMA-Directed CAR T Cell Therapy
February 24, 2021
From
Business Wire News Releases
European Medicines Agency's CHMP Backs Approval Of Cabometyx/Opdivo Combo In Kidney Cancer
February 26, 2021
Tags
Benzinga
BMY
Health Care
From
Benzinga
3 Top Stocks That'll Make You Richer in March (and Beyond)
March 01, 2021
Tags
GOLD
Market News
FB
From
Motley Fool
5 Deep Value Dividend Stocks For Annual Portfolio Rebalancing
February 26, 2021
Tags
Stocks / Equities
Market News
From
Blogs - TalkMarkets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.